Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Tyra Biosciences, Inc. (TYRA) had Non-Operating Income/Expense of $3.44M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-45.56M |
|
-- |
|
-- |
|
$49.00M |
|
$-49.00M |
|
|
Non-Operating Income/Expense |
$3.44M |
$-45.56M |
|
$-45.56M |
|
$-45.56M |
|
$-45.56M |
|
$-45.56M |
|
$-45.56M |
|
$-49.00M |
|
$-48.87M |
|
65.99M |
|
65.99M |
|
$-0.69 |
|
$-0.69 |
|
| Balance Sheet Financials | |
$366.97M |
|
$1.17M |
|
$16.40M |
|
$383.36M |
|
$24.62M |
|
-- |
|
$5.08M |
|
$29.70M |
|
$353.66M |
|
$353.66M |
|
$353.66M |
|
59.66M |
|
| Cash Flow Statement Financials | |
$-63.65M |
|
$-102.39M |
|
$162.49M |
|
$78.39M |
|
$74.83M |
|
$-3.55M |
|
$18.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.91 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-63.80M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.88% |
|
-12.88% |
|
-11.88% |
|
-12.88% |
|
$5.93 |
|
$-0.97 |
|
$-0.96 |
|